Concord Wealth Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138K | Buy |
4,998
+4,758
| +1,983% | +$131K | 0.02% | 240 |
|
|
2025
Q1 | $6.8K | Buy |
240
+108
| +82% | +$3.06K | ﹤0.01% | 544 |
|
|
2024
Q4 | $5.49K | Sell |
132
-378
| -74% | -$15.7K | ﹤0.01% | 590 |
|
|
2024
Q3 | $34.1K | Buy |
510
+100
| +24% | +$6.68K | 0.01% | 390 |
|
|
2024
Q2 | $48.6K | Buy |
410
+278
| +211% | +$33K | 0.01% | 312 |
|
|
2024
Q1 | $14.1K | Sell |
132
-72
| -35% | -$7.67K | ﹤0.01% | 537 |
|
|
2023
Q4 | $20.3K | Hold |
204
| – | – | ﹤0.01% | 476 |
|
|
2023
Q3 | $21.1K | Hold |
204
| – | – | ﹤0.01% | 503 |
|
|
2023
Q2 | $24.8K | Hold |
204
| – | – | 0.01% | 472 |
|
|
2023
Q1 | $31.3K | Hold |
204
| – | – | 0.01% | 419 |
|
|
2022
Q4 | $36.6K | Buy |
+204
| New | +$36.6K | 0.01% | 421 |
|
|
2022
Q3 | – | Sell |
-204
| Closed | -$29K | – | 745 |
|
|
2022
Q2 | $29K | Hold |
204
| – | – | 0.01% | 460 |
|
|
2022
Q1 | $35K | Sell |
204
-98
| -32% | -$16.8K | 0.01% | 497 |
|
|
2021
Q4 | $77K | Buy |
302
+230
| +319% | +$58.6K | 0.02% | 353 |
|
|
2021
Q3 | $28K | Hold |
72
| – | – | 0.01% | 315 |
|
|
2021
Q2 | $17K | Sell |
72
-57
| -44% | -$13.5K | ﹤0.01% | 539 |
|
|
2021
Q1 | $17K | Buy |
129
+57
| +79% | +$7.51K | 0.01% | 505 |
|
|
2020
Q4 | $8K | Buy |
+72
| New | +$8K | 0.01% | 376 |
|